A detailed history of Plante Moran Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 590 shares of NVO stock, worth $49,825. This represents 0.01% of its overall portfolio holdings.

Number of Shares
590
Previous 590 -0.0%
Holding current value
$49,825
Previous $84,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $16,565 - $19,832
135 Added 29.67%
590 $84,000
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $9,700 - $12,912
-95 Reduced 17.27%
455 $58,000
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $38,623 - $46,398
-440 Reduced 44.44%
550 $56,000
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $45,015 - $98,772
495 Added 100.0%
990 $90,000
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $42,558 - $56,161
415 Added 518.75%
495 $66,000
Q3 2022

Nov 02, 2022

SELL
$95.28 - $116.93 $9,051 - $11,108
-95 Reduced 54.29%
80 $8,000
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $9,807 - $11,571
95 Added 118.75%
175 $20,000
Q2 2021

Aug 10, 2021

SELL
$67.66 - $84.76 $5,412 - $6,780
-80 Reduced 50.0%
80 $7,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $10,729 - $12,131
160 New
160 $11,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $4,636 - $5,418
-93 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $37,271 - $41,889
-784 Reduced 89.4%
93 $4,000
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $40,657 - $46,156
877 New
877 $46,000
Q3 2018

Nov 09, 2018

SELL
$46.76 - $51.24 $208,222 - $228,171
-4,453 Closed
0 $0
Q2 2018

Jul 26, 2018

BUY
$44.29 - $50.42 $93,451 - $106,386
2,110 Added 90.06%
4,453 $205,000
Q1 2018

May 01, 2018

BUY
$48.49 - $58.14 $112,787 - $135,233
2,326 Added 13682.35%
2,343 $115,000
Q3 2017

Nov 08, 2017

BUY
$41.15 - $49.22 $699 - $836
17
17 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.